Rosalia
Fernández Alonso
Dana–Farber Cancer Institute
Boston, Estados UnidosPublications en collaboration avec des chercheurs de Dana–Farber Cancer Institute (1)
2016
-
Erk5 Is a Key Regulator of Naive-Primed Transition and Embryonic Stem Cell Identity
Cell Reports, Vol. 16, Núm. 7, pp. 1820-1828